Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other 1

Conditions

Polycystic Ovary Syndrome 1Overweight 1Obesity 1Insulin Resistance 1Hyperandrogenism 1

Interventions

Radiotherapy 9naloxegol 7Metformin 7Surveys and Questionnaires 6Cisplatin 6Exenatide 4Vitamin D 3Sugars 3Fibroblast Growth Factor 7 3Water 2Therapeutics 2Testosterone 2Resistance Training 2Radiation 2Nutrition Assessment 2Methods 2Low-Level Light Therapy 2Injections 2Fentanyl 2Drug Therapy 2Dexamethasone 2Cryotherapy 2Calcium Dobesilate 2Anastrozole 2prucalopride 1peppermint oil 1penclomedine 1pegfilgrastim 1oxycodone-acetaminophen 1methylnaltrexone 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × licogliflozin × Other × Clear all
NCT03152591 2021-01-05

PCOS

Novartis

Phase 2 Completed
29 enrolled 24 charts
Other

Insulin Resistance, Obesity, Polycystic Ovary Syndrome, Hyperandrogenism, Overweight

Data powered by HemOnc (CC BY 4.0) Colophon âš¡